Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

14.35
Delayed Data
As of Apr 28
 +0.35 / +2.50%
Today’s Change
8.82
Today|||52-Week Range
19.90
-4.65%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Revenue and IncomeNet Revenues19.9M26.4M29.1M34.2M
 
 
 
 
 
Depreciation And Amortization2.2M2.5M2.3M2.2M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses42.3M45.5M45.1M42.4M
 
 
 
 
 
Research And Development28.8M33.2M31.6M26.4M
 
 
 
 
 
Total Operating Expenses44.4M48.1M47.3M44.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-24.6M-21.6M-18.2M-10.4M
 
 
 
 
 
Extraordinary Credit0.000.000.0051.2M
 
 
Other Expenses62.0K62.0K38.0K65.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-24.0M-21.0M-17.5M41.5M
 
 
 
 
 
Net Income-24.0M-21.0M-17.5M41.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS68.3M68.5M68.8M69.0M
 
 
 
 
 
Shares To Calculate EPS Diluted68.3M68.5M68.8M69.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.35-$0.31-$0.26$0.60
 
 
 
 
 
EPS Diluted-$0.35-$0.31-$0.26$0.60